Sanitas Healthcare Revenue

About Sanitas Healthcare

Sanitas Healthcare Plc (formerly PatientPak Ltd) began trading in 2007 when we launched our first product, PatientPak. This product is the world’s first personal anti-superbug kit, designed to protect hospital patients and their visitors from superbugs such as MRSA and Norovirus The kit contains a comprehensive range of antimicrobial items. The antimicrobial formula contained in Sanitas Healthcare products has been developed by medical doctors in the UK and is widely used in the NHS in the UK. It is proven to kill 99.9% of germs, is non toxic, skin-safe and environmentally friendly, and has been extensively tested to European Standards. Since the inception of PatientPak our company has undergone simultaneous expansion of both its brands and personnel. This has been possible due to the huge success of PatientPak and our second product FluPak in the UK and Europe. Hugely successful Medica and Arab Health exhibitions have also facilitated the expansion of the Sanitas distribution network, which now stretches from the UK, across Europe, the Middle East and down to Oceania. Arab Health 2010 culminated in the presentation of the Lord Darzi award for 'most innovative new product for export', reflecting the great success enjoyed by Sanitas Healthcare over the past 3 years. Our complete range of antimicrobial products includes, new for 2010, SchoolPak and FemPak. The products we carry are all designed to combat the spread of infections and are tailored to a variety of different situations so that consumers can feel empowered by the ability to control their external environment. Our range now includes PatientPak, TravelPak, FluPak, ProtectPak, ProtectPak Medical, SchoolPak and HajPak, as well as our standalone products such as ProtectGel, ProtectMasks, ProtectSpray and ProtectWipes.

View contact profiles from Sanitas Healthcare